![]() |
市場調查報告書
商品編碼
2177875
神經美容市場預測至2034年-按產品類型、產品形態、應用、通路、最終用戶、皮膚類型和地區分類的全球分析Neurocosmetics Market Forecasts to 2034 - Global Analysis By Product Type, Product Form, Application, Distribution Channel, End User, Skin Type and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球神經美容市場規模將達到 12 億美元,並在預測期內以 10.2% 的複合年成長率成長,到 2034 年將達到 26 億美元。
神經美容產品是旨在透過調節與感覺知覺和壓力相關的皮膚反應,與皮膚神經感覺系統相互作用的局部護膚配方。這些產品含有神經肽、感覺調節植物成分以及冷熱成分,能夠影響皮膚中神經傳導物質和神經肽的釋放。這些配方旨在減少不適感、緊繃感和敏感度,同時維持皮膚屏障功能的舒適性。它們有精華液、乳霜、乳液、凝膠和面膜等多種劑型,適用於乾性、油性和混合性皮膚。
人們對神經感覺護膚的興趣日益濃厚
消費者越來越意識到皮膚反應與感覺和壓力通路密切相關,因此對不僅能保濕還能緩解不適的產品越來越感興趣。各大品牌紛紛在高階精華液和乳霜中強調神經肽和植物來源活性成分,並輔以網紅推廣和皮膚科醫生推薦。這種市場定位推高了產品價格,並促使尋求溫和舒緩護膚的消費者重複購買,從而增加了已開發國家專賣店和電商通路的貨架空間。
臨床療效有限
由於目前尚缺乏獨立的臨床證據來證明局部應用神經肽與可測量的感官效應之間存在關聯,皮膚科醫生在推薦此類配方而非使用現有的鎮靜活性成分時持謹慎態度。在某些市場,提及神經傳導物質調節的聲明正受到嚴格的監管審查,導致合規成本增加和新產品上市延遲。缺乏可靠的對比試驗使得品牌難以證明其高價策略的合理性,而懷疑的消費者可能會重新選擇傳統的皮膚屏障護理產品。因此,早期採用者和產品線在專業管道之外的擴張都受到限制。
對敏感肌膚的需求
自述敏感肌膚的日益普遍,為神經護膚產品提供了市場機遇,這些產品被定位為強效活性成分的「溫和」替代品。藥局和皮膚科診所通路為產品教育提供了可靠的平台,而具有清涼和溫熱效果的產品則透過切實的感官刺激,強化了消費者對其功效的認知。將神經胜肽與神經醯胺和泛醇結合的產品,能夠在不刺激皮膚的情況下緩解泛紅和緊繃感。隨著消費者簡化護膚步驟,明確定位為敏感肌膚適用的產品,有助於在藥局和專業零售通路獲得更高的定價和更持久的顧客忠誠度。
使用屏障護理產品的替代方案
含有神經醯胺、泛醇和膠體燕麥的成熟屏障霜價格低廉,且具有廣泛臨床認可的舒緩效果,這降低了消費者為神經美容產品支付高價的意願。許多消費者認為這些傳統產品足以應付敏感肌膚。如果主流品牌開始在其現有屏障產品系列中宣傳“感官舒適”,神經美容精華液可能難以脫穎而出,品牌必須證明其獨特的神經感官功效才能獲得貨架空間和價格優勢。
疫情期間,由於戴口罩加劇了皮膚刺激和不適感,人們對皮膚反應的關注度顯著提升。危機期間,消費者轉向舒緩、無香型產品,並開始在網路上搜尋感官護膚訊息,這推動了神經美容產品的早期普及。疫情過後,人們對溫和舒緩壓力的護膚的需求持續成長。同時,各大品牌拓展了電商銷售網路,並加強了臨床支持,以鞏固其在全球藥局和專業零售通路的高階定位。
在預測期內,基於神經肽的化妝品細分市場預計將佔據最大的市場佔有率。
預計在預測期內,基於神經肽的化妝品細分市場將佔據最大的市場佔有率。這是因為其定位直接聚焦於感官舒適度和肌膚反應,迎合了那些尋求溫和替代強效活性成分的消費者的需求。這些配方在透過專業零售商和皮膚科通路銷售的高階精華液和乳霜中佔據主導地位,品牌推廣活動也不斷強化消費者對其功效的認知。隨著人們對敏感肌膚問題的日益關注,基於神經肽的產品仍然是該品類的中流砥柱,在整個市場中保持領先的銷售佔有率。
在預測期內,血清產品細分市場預計將呈現最高的複合年成長率。
在預測期內,精華液細分市場預計將呈現最高的成長率,這主要得益於消費者對質地輕盈、吸收迅速且能將高濃度活性成分輸送到保濕霜之下的產品的偏好。精華液有助於在多步驟護膚流程中疊加使用,並使品牌能夠在高價位產品中突出神經肽的濃度。隨著配方研發人員不斷提升產品的穩定性和易用性,以及品牌自有電商平台和專業零售商處新品精華液的激增,該細分市場已成為同類產品中成長最快的品類。
在整個預測期內,北美預計將保持最大的市場佔有率,這得益於其在高階護膚上的高額支出、完善的皮膚科醫療保健基礎設施以及消費者對神經科學理念的熟悉程度。美國是區域銷售的主要驅動力,這得益於專業零售商和品牌對臨床試驗的投資。對敏感肌膚新創企業的積極創業融資以及D2C(直接面對消費者)模式的快速普及,進一步鞏固了該地區在神經美容領域的領先地位,而連鎖藥局則為教育和試驗提供了值得信賴的平台。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於韓國、中國、日本和印度等國家多步驟護膚流程的普及、消費者對敏感肌膚日益成長的關注以及優質化的快速發展。消費者正積極使用舒緩精華液和乳霜,而本土品牌和契約製造生產商也不斷提升其神經肽配方能力。加之藥局和電商通路的日益普及以及皮膚科教育計畫的實施,亞太地區已成為神經化妝品市場成長最快的地區。
北美洲
我們
加拿大
墨西哥
歐洲
英國
德國
法國
義大利
西班牙
荷蘭
比利時
瑞典
瑞士
波蘭
其他歐洲國家
亞太地區
中國
日本
印度
韓國
澳洲
印尼
泰國
馬來西亞
新加坡
越南
亞太其他地區
南美洲
巴西
阿根廷
哥倫比亞
智利
秘魯
南美洲其他地區
世界其他地區(RoW)
中東
沙烏地阿拉伯
阿拉伯聯合大公國
卡達
以色列
其他中東國家
非洲
南非
埃及
摩洛哥
其他非洲國家
企業概況
對其他市場參與者(最多 3 家公司)進行全面分析
對主要公司進行SWOT分析(最多3家公司)
區域細分
根據客戶要求,我們可以提供主要國家的市場估算和預測,以及複合年成長率(註:需經可行性確認)。
競爭性標竿分析
According to Stratistics MRC, the Global Neurocosmetics Market is accounted for $1.2 billion in 2026 and is expected to reach $2.6 billion by 2034 growing at a CAGR of 10.2% during the forecast period. Neurocosmetics are topical skincare formulations designed to interact with the skin's neurosensory system by modulating sensory perception and stress-related skin responses. They contain neuropeptides, sensory-modulating botanicals, and cooling or warming agents that influence the release of neurotransmitters and neuropeptides within the skin. These formulations aim to reduce sensations of discomfort, tightness, and reactivity while supporting barrier comfort. They are applied as serums, creams, lotions, gels, and masks to dry, oily, and combination skin.
Rising Neurosensory Skincare Interest
Consumers are increasingly aware that skin reactivity is linked to sensory and stress pathways, which encourages interest in formulations that calm discomfort rather than only moisturize. Brands highlight neuropeptide and botanical actives in premium serums and creams, supported by influencer education and dermatology commentary. This positioning supports higher price points and repeat purchase among buyers seeking gentle, soothing routines, thereby expanding shelf presence across specialty retail and e-commerce channels in developed markets.
Limited Clinical Validation
Independent clinical evidence linking topical neuropeptides to measurable sensory outcomes remains limited, which makes dermatologists cautious about recommending these formulations over established soothing actives. Claims referencing neurotransmitter modulation attract regulatory scrutiny in several markets, raising compliance costs and slowing launches. Without robust comparative trials, brands struggle to defend premium pricing, and skeptical consumers may revert to conventional barrier products, thereby constraining category expansion beyond early adopters and specialist channels.
Sensitive Skin Demand
Growing prevalence of self-reported sensitive skin creates opportunity for neurocosmetic products positioned as gentle alternatives to strong actives. Pharmacy and dermatology channels provide credible platforms for education, while cooling and warming formats offer tangible sensory cues that reinforce perceived efficacy. Brands that pair neuropeptides with ceramides and panthenol can address redness and tightness without irritation. As consumers simplify routines, clear sensitive-skin identity supports premium pricing and durable loyalty across pharmacy and specialty retail channels.
Substitution by Barrier Products
Established barrier creams containing ceramides, panthenol, and colloidal oatmeal deliver soothing benefits at lower cost and with broader clinical familiarity, which reduces willingness to pay premiums for neurocosmetic positioning. Many consumers perceive these conventional products as sufficient for reactive skin. If mainstream brands add sensory-comfort claims to existing barrier lines, neurocosmetic serums may struggle to differentiate, and brands must substantiate unique neurosensory benefits to defend shelf space and pricing.
The pandemic heightened attention to skin reactivity as mask-wearing increased irritation and discomfort. During the crisis, consumers shifted toward soothing, fragrance-free formulations and researched sensory skincare online, supporting early neurocosmetic trial. Post-pandemic, sustained interest in gentle, stress-focused routines has reinforced demand, while brands expanded e-commerce distribution and clinical substantiation to support premium positioning across pharmacy and specialty retail channels globally.
The Neuropeptide-Based Cosmetics segment is expected to be the largest during the forecast period
The Neuropeptide-Based Cosmetics segment is expected to account for the largest market share during the forecast period, due to their direct positioning around sensory comfort and skin reactivity, which appeals to consumers seeking gentle alternatives to strong actives. These formulations feature prominently in premium serums and creams sold through specialty retail and dermatology channels, while brand education reinforces perceived efficacy. As sensitive-skin concerns grow, neuropeptide-based products remain the category anchor, thereby sustaining leading revenue share across the market.
The Serums segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the Serums segment is predicted to witness the highest growth rate, driven by consumer preference for lightweight, fast-absorbing formats that deliver concentrated actives beneath moisturizers. Serums support layering within multi-step routines and allow brands to highlight neuropeptide concentration at premium price points. As formulators improve stability and sensory texture, serum launches multiply across brand-owned e-commerce and specialty retail, making this the fastest-growing product form segment in the category.
During the forecast period, the North America region is expected to hold the largest market share, due to high premium skincare spending, strong dermatology infrastructure, and consumer familiarity with neuroscience-inspired positioning. The United States dominates regional revenue, supported by specialty retailers and brands investing in clinical substantiation. Active venture funding for sensitive-skin startups and rapid direct-to-consumer adoption further reinforce the region's leading position in neurocosmetics, while pharmacy chains provide credible platforms for education and trial.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to deeply embedded multi-step routines, rising sensitive-skin concerns, and rapid premiumization across South Korea, China, Japan, and India. Consumers readily adopt soothing serums and creams, while local brands and contract manufacturers expand neuropeptide formulation capability. Growing pharmacy and e-commerce availability, combined with dermatology education programs, makes Asia Pacific the fastest-growing regional market for neurocosmetics.
Key players in the market
Some of the key players in Neurocosmetics Market include L'Oreal S.A., The Estee Lauder Companies Inc., Beiersdorf AG, Shiseido Company, Limited, Unilever PLC, The Procter & Gamble Company, Kao Corporation, Kenvue Inc., Amorepacific Corporation, LG H&H Co., Ltd., Coty Inc., Natura &Co, Edgewell Personal Care Company, Galderma Group AG, Pierre Fabre Laboratories, and Rohto Pharmaceutical Co., Ltd.
In October 2026, L'Oreal S.A. launched a neuropeptide serum positioned for sensory comfort and barrier support, supported by dermatological tolerance testing and distributed through specialty retailers and brand-owned e-commerce across European and North American markets.
In September 2026, Beiersdorf AG expanded its soothing skincare range with cooling-sensation gels and creams formulated for reactive skin, supported by clinical education programs and distributed through pharmacies and medical spa channels across European markets.
In August 2026, Amorepacific Corporation introduced sensory-modulating botanical masks and serums designed for stress-response skincare, distributed through specialty retailers and online marketplaces with digital education campaigns across South Korea and Southeast Asia.
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
France
Italy
Spain
Netherlands
Belgium
Sweden
Switzerland
Poland
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Thailand
Malaysia
Singapore
Vietnam
Rest of Asia Pacific
South America
Brazil
Argentina
Colombia
Chile
Peru
Rest of South America
Rest of the World (RoW)
Middle East
Saudi Arabia
United Arab Emirates
Qatar
Israel
Rest of Middle East
Africa
South Africa
Egypt
Morocco
Rest of Africa
Company Profiling
Comprehensive profiling of additional market players (up to 3)
SWOT Analysis of key players (up to 3)
Regional Segmentation
Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.